Search tips
Search criteria 


Logo of envhperEnvironmental Health PerspectivesBrowse ArticlesAbout EHPGeneral InformationAuthorsMediaProgramsPartnerships
Environ Health Perspect. 1996 April; 104(4): 408–413.
PMCID: PMC1469335
Research Article

Identification of anovulation and transient luteal function using a urinary pregnanediol-3-glucuronide ratio algorithm.


The sensitivity and specificity of a urinary pregnanediol-3-glucuronide (PdG) ratio algorithm to identify anovulatory cycles was studied prospectively in two independent populations of women. Urinary hormone data from the first group was used to develop the algorithm, and data from the second group was used for its validation. PdG ratios were calculated by a cycles method in which daily PdG concentrations indexed by creatinine (CR) from cycle day 11 onward were divided by a baseline PdG (average PdG/Cr concentration for cycle days 6-10). In the interval method, daily PdG/CR concentrations from day 1 onward were divided by baseline PdG (lowest 5-day average of PdG/CR values throughout the collection period). Evaluation of the first study population (n = 6) resulted in cycles with PdG ratios > or = 3 for > or = 3 consecutive days being classified as ovulatory; otherwise they were anovulatory. The sensitivity and specificity of the PdG ratio algorithm to identify anovulatory cycles in the second population were 75% and 89.5%, respectively, for all cycles (n = 88); 50% and 88.3% for first cycles (n = 40) using the cycles method; 75% and 92.2%, respectively, for all cycles (n = 89); and 50% and 94.1% for first cycles (n = 40) using the interval method. The "gold standard" for anovulation was weekly serum samples < or = 2 ng/ml progesterone. The sensitivity values for all cycles and for the first cycle using both methods were underestimated because of apparent misclassification of cycles using serum progesterone due to infrequent blood collection. Blood collection more than once a week would have greatly improved the sensitivity and modestly improved the specificity of the algorithm. The PdG ratio algorithm provides an efficient approach for screening urine samples collected in epidemiologic studies of reproductive health in women.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.8M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • De Rosis F, Anastasio SP, Selvaggi L, Beltrame A, Moriani G. Female reproductive health in two lamp factories: effects of exposure to inorganic mercury vapour and stress factors. Br J Ind Med. 1985 Jul;42(7):488–494. [PMC free article] [PubMed]
  • Shortridge LA. Assessment of menstrual variability in working populations. Reprod Toxicol. 1988;2(3-4):171–176. [PubMed]
  • LaRosa JC. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women? Womens Health Issues. 1992 Summer;2(2):102–113. [PubMed]
  • Drinkwater BL, Nilson K, Chesnut CH, 3rd, Bremner WJ, Shainholtz S, Southworth MB. Bone mineral content of amenorrheic and eumenorrheic athletes. N Engl J Med. 1984 Aug 2;311(5):277–281. [PubMed]
  • Secreto G, Zumoff B. Abnormal production of androgens in women with breast cancer. Anticancer Res. 1994 Sep-Oct;14(5B):2113–2117. [PubMed]
  • Gidwani GP. Gynecologic problems of androgen excess. Cleve Clin J Med. 1990 May;57(3):288–291. [PubMed]
  • Fraser IS. Menorrhagia--a pragmatic approach to the understanding of causes and the need for investigations. Br J Obstet Gynaecol. 1994 Jul;101 (Suppl 11):3–7. [PubMed]
  • Askalani H, Smuk M, Sugar J, Delvoye P, Robyn C, Schwers J. Serum progesterone in nonpregnant women. I. Comparative study of serum progesterone concentration and urinary pregnanediol excretion. Am J Obstet Gynecol. 1974 Apr 15;118(8):1054–1063. [PubMed]
  • Lasley BL, Lohstroh P, Kuo A, Gold EB, Eskenazi B, Samuels SJ, Stewart DR, Overstreet JW. Laboratory methods for evaluating early pregnancy loss in an industry-based population. Am J Ind Med. 1995 Dec;28(6):771–781. [PubMed]
  • Baird DD, Weinberg CR, Wilcox AJ, McConnaughey DR, Musey PI. Using the ratio of urinary oestrogen and progesterone metabolites to estimate day of ovulation. Stat Med. 1991 Feb;10(2):255–266. [PubMed]
  • Stewart DR, Cragun JR, Boyers SP, Oi R, Overstreet JW, Lasley BL. Serum relaxin concentrations in patients with out-of-phase endometrial biopsies. Fertil Steril. 1992 Feb;57(2):453–455. [PubMed]
  • Munro CJ, Stabenfeldt GH, Cragun JR, Addiego LA, Overstreet JW, Lasley BL. Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay. Clin Chem. 1991 Jun;37(6):838–844. [PubMed]
  • Judd S, Terry A, Petrucco M, White G. The source of pulsatile secretion of progesterone during the human follicular phase. J Clin Endocrinol Metab. 1992 Feb;74(2):299–305. [PubMed]
  • Zumoff B, Miller L, Levin J, Levit CD, Miller EH, Heinz U, Kalin M, Denman H, Jandorek R, Rosenfeld RS. Follicular-phase serum progesterone levels of nonsmoking women do not differ from the levels of nonsmoking men. Steroids. 1990 Dec;55(12):557–559. [PubMed]
  • Friedman AJ, Ravnikar VA, Barbieri RL. Serum steroid hormone profiles in postmenopausal smokers and nonsmokers. Fertil Steril. 1987 Mar;47(3):398–401. [PubMed]
  • Key TJ, Pike MC, Baron JA, Moore JW, Wang DY, Thomas BS, Bulbrook RD. Cigarette smoking and steroid hormones in women. J Steroid Biochem Mol Biol. 1991 Oct;39(4A):529–534. [PubMed]
  • Zumoff B, Miller L, Levit CD, Miller EH, Heinz U, Kalin M, Denman H, Jandorek R, Rosenfeld RS. The effect of smoking on serum progesterone, estradiol, and luteinizing hormone levels over a menstrual cycle in normal women. Steroids. 1990 Nov;55(11):507–511. [PubMed]
  • Gold EB, Eskenazi B, Hammond SK, Lasley BL, Samuels SJ, O'Neill Rasor M, Hines CJ, Overstreet JW, Schenker MB. Prospectively assessed menstrual cycle characteristics in female wafer-fabrication and nonfabrication semiconductor employees. Am J Ind Med. 1995 Dec;28(6):799–815. [PubMed]
  • Eskenazi B, Gold EB, Lasley BL, Samuels SJ, Hammond SK, Wight S, O'Neill Rasor M, Hines CJ, Schenker MB. Prospective monitoring of early fetal loss and clinical spontaneous abortion among female semiconductor workers. Am J Ind Med. 1995 Dec;28(6):833–846. [PubMed]
  • Ayabe T, Tsutsumi O, Momoeda M, Yano T, Mitsuhashi N, Taketani Y. Impaired follicular growth and abnormal luteinizing hormone surge in luteal phase defect. Fertil Steril. 1994 Apr;61(4):652–656. [PubMed]
  • Soules MR, Clifton DK, Cohen NL, Bremner WJ, Steiner RA. Luteal phase deficiency: abnormal gonadotropin and progesterone secretion patterns. J Clin Endocrinol Metab. 1989 Oct;69(4):813–820. [PubMed]
  • Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil. 1967 Jan-Mar;12(1 Pt 2):77–126. [PubMed]
  • Harlow SD, Matanoski GM. The association between weight, physical activity, and stress and variation in the length of the menstrual cycle. Am J Epidemiol. 1991 Jan;133(1):38–49. [PubMed]
  • Aksel S. Hormonal characteristics of long cycles in fertile women. Fertil Steril. 1981 Oct;36(4):521–523. [PubMed]
  • Matsumoto S, Tamada T, Konuma S. Endocrinological analysis of environmental menstrual disorders. Int J Fertil. 1979;24(4):233–239. [PubMed]
  • Keizer HA, Rogol AD. Physical exercise and menstrual cycle alterations. What are the mechanisms? Sports Med. 1990 Oct;10(4):218–235. [PubMed]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Science